Clinical trial
Effects of 4-month Therapy of Levothyroxine on Non-Alcoholic Fatty Liver Disease (NAFLD) and Diabetes Control in Diabetic Patients
NCT03281083 is registered in ClinicalTrials.gov with Duke-NUS Graduate Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of 4-month Therapy of Levothyroxine on Non-Alcoholic Fatty Liver Disease (NAFLD) and Diabetes Control in Diabetic Patients
- Lead sponsor
- Duke-NUS Graduate Medical School
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 28, 2014
- Completion date
- July 28, 2016
- Enrollment
- 29 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.